I-ne CO (4933) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
16 Oct, 2026Executive summary
Q1 FY2025 revenue rose 22.4% YoY to ¥11.116bn; operating income increased 41.3% to ¥901m and EBITDA rose 83.2% to ¥1,316m.
Sales were broadly on plan, with strong profit growth supported by skincare expansion and acquisition contributions from TOUT VERT and Artemis.
Profit attributable to owners of parent was ¥373m, up 7.2% YoY; comprehensive income was ¥398m.
Financial highlights
Gross profit increased to ¥6,240m from ¥4,836m; cost of sales ratio improved to 43.9% from 46.7%.
Operating margin was 8.1%, versus 7.0% a year earlier; EBITDA margin rose to 11.8% from 7.9%.
Basic EPS was ¥21.37, compared with ¥23.98 in Q1 FY2024; ordinary income was ¥840m.
Total assets were ¥36,424m and net assets ¥17,998m as of March 31, 2025; capital adequacy ratio was 45.7%.
Segment performance
Haircare sales were ¥6.37bn, up 3.1% YoY; domestic sales excluding overseas revenue rose 5.9%. YOLU grew 18.0%, while BOTANIST declined amid the China market exit.
Beauty appliances revenue was ¥2.57bn, up 3.9%; sales of products priced at ¥6,000 or more grew 82.1%, supporting margin improvement.
Skincare and related revenue rose 410.9% to ¥2.16bn; excluding TOUT VERT, sales increased 102.5%. TOUT VERT contributed ¥1.30bn and other brands ¥850m.
TOUT VERT recorded its highest January–March sales; WrinkFade grew 44.8% YoY, and ReWEAR sold 3,000 units in one hour during online test sales.
Latest events from I-ne CO
- 9M sales rose 24.6%, while profits fell and FY2026 sales guidance increased.4933
Q3 2026 - H1 sales rose 20.1%, lifting guidance despite cost pressures and a lower full-year profit outlook.4933
Q2 2026 - H1 sales and EBITDA grew as skincare and online gains offset haircare and M&A profit pressure.4933
Q2 2025 - Sales and EBITDA grew, but attributable profit fell amid uneven category performance.4933
Q3 2025 - Q1 sales rose 12.4%, while profit fell amid higher investment and one-time losses.4933
Q1 2026 - Skincare and online growth lifted sales as acquisition costs and FY2026 guidance weighed on profit.4933
Q4 2025